Flosonics Expands Wearable Ultrasound in New Hospital Deal

By

Disclaimer: Images on MEDWIRE.AI are AI-generated for illustrative purposes and are not affiliated with, endorsed by, or representative of any specific company, product, or technology.

Flosonics has expanded the use of its FloPatch wearable Doppler ultrasound device across additional Sutter Health hospitals, marking a key milestone in the adoption of real-time, non-invasive hemodynamic monitoring.

The latest deployment includes Sutter’s Alta Bates Summit Medical Center in Oakland and Santa Rosa Regional Hospital in Sonoma County. These implementations span various departments, including the ICU, emergency, telemetry, and medical-surgical units, bringing the total number of Sutter campuses using FloPatch to six within the past year.

FloPatch, developed by Sudbury-based Flosonics, offers clinicians a rapid, repeatable solution to assess blood flow and guide IV fluid management—a critical intervention after surgery. The device provides real-time data in under three minutes, helping prevent complications from unnecessary fluid administration, which can prolong hospital stays.

Joe Eibl, CEO and co-founder of Flosonics, highlighted the partnership as evidence of how leading health systems are embracing innovation to tackle clinical challenges.

Follow MEDWIRE.AI for the latest on wearable health tech and hospital innovation.